What do systematic reviews say?

Summary of findings table ‐ Early developmental intervention programmes vs standard follow‐up

• Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment… 2024 · Cochrane Headline outcomes only
  no estimate extracted
  9 studies · 1524 participants
  High

Summary of findings table ‐ Early developmental intervention programmes vs standard follow‐up

• Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment… 2024 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 264 participants
  Moderate

Early treatment vs expectant management

Early treatment showed no clear difference in all‐cause mortality during hospital stay compared with expectant management (moderate certainty).

• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants 2020 · Cochrane Headline outcomes only
  RR 0.8 [0.46, 1.39]
  6 studies · 500 participants
  Moderate

Early treatment vs expectant management

It is very uncertain whether early treatment changes proportion of infants requiring surgical PDA ligation or… compared with expectant management (very low certainty).

• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants 2020 · Cochrane Headline outcomes only
  RR 1.08 [0.65, 1.8]
  4 studies · 432 participants
  Very low

Early treatment vs expectant management

Early treatment may leads to higher proportion of infants receiving any pharmacotherapy for a… compared with expectant management (low certainty).

• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants 2020 · Cochrane Headline outcomes only
  RR 2.3 [1.86, 2.83]
  2 studies · 232 participants
  Low

Early treatment vs expectant management

Early treatment showed no clear difference in chronic lung disease compared with expectant management (moderate certainty).

• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants 2020 · Cochrane Headline outcomes only
  RR 0.9 [0.62, 1.29]
  4 studies · 339 participants
  Moderate

Early treatment vs expectant management

Early treatment showed no clear difference in severe Intraventricular hemorrhage (grades III and IV) compared with expectant management (low certainty).

• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants 2020 · Cochrane Headline outcomes only
  RR 0.83 [0.32, 2.16]
  2 studies · 171 participants
  Low

Early treatment vs expectant management

Early treatment showed no clear difference in necrotizing enterocolitis (NEC; stage 2 or greater) compared with expectant management (low certainty).

• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants 2020 · Cochrane Headline outcomes only
  RR 2.34 [0.86, 6.41]
  5 studies · 473 participants
  Low

Very early treatment vs expectant management

Very early treatment showed no clear difference in chronic lung disease compared with expectant management (low certainty).

• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants 2020 · Cochrane Headline outcomes only
  RR 0.83 [0.63, 1.08]
  7 studies · 384 participants
  Low

Very early treatment vs expectant management

Very early treatment showed no clear difference in severe Intraventricular hemorrhage (grades III and IV) compared with expectant management (moderate certainty).

• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants 2020 · Cochrane Headline outcomes only
  RR 0.64 [0.21, 1.93]
  4 studies · 240 participants
  Moderate

Very early treatment vs expectant management

Very early treatment showed no clear difference in necrotizing enterocolitis (NEC; stage 2 or greater) compared with expectant management (moderate certainty).

• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants 2020 · Cochrane Headline outcomes only
  RR 1.08 [0.53, 2.21]
  5 studies · 332 participants
  Moderate

Very early treatment vs expectant management

• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants 2020 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 240 participants
  Low

Very early treatment vs expectant management

Very early treatment showed no clear difference in neurodevelopmental outcomes (moderate/severe cognitive delay at 18… compared with expectant management (low certainty).

• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants 2020 · Cochrane Headline outcomes only
  RR 0.27 [0.03, 2.31]
  1 study · 79 participants
  Low

Very early treatment vs expectant management

Very early treatment showed no clear difference in neurodevelopmental outcomes (moderate/severe motor delay at 18 to 24… compared with expectant management (low certainty).

• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants 2020 · Cochrane Headline outcomes only
  RR 0.54 [0.05, 5.71]
  1 study · 79 participants
  Low

Very early treatment vs expectant management

Very early treatment showed no clear difference in neurodevelopmental outcomes (moderate/severe language delay at 18 to… compared with expectant management (low certainty).

• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants 2020 · Cochrane Headline outcomes only
  RR 0.54 [0.1, 2.78]
  1 study · 79 participants
  Low

Very early treatment vs expectant management

Very early treatment showed no clear difference in all‐cause mortality during hospital stay compared with expectant management (moderate certainty).

• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants 2020 · Cochrane Headline outcomes only
  RR 0.94 [0.58, 1.53]
  7 studies · 384 participants
  Moderate

Very early treatment vs expectant management

Very early treatment showed no clear difference in proportion of infants requiring surgical PDA ligation or… compared with expectant management (moderate certainty).

• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants 2020 · Cochrane Headline outcomes only
  RR 0.88 [0.36, 2.17]
  5 studies · 293 participants
  Moderate

Very early treatment vs expectant management

It is very uncertain whether very early treatment changes proportion of infants receiving any pharmacotherapy for a… compared with expectant management (very low certainty).

• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants 2020 · Cochrane Headline outcomes only
  RR 1.64 [1.31, 2.05]
  4 studies · 156 participants
  Very low

Early paracetamol vs placebo or no intervention

Early paracetamol may leads to lower failure of PDA closure after first course of treatment (by… compared with placebo/no intervention (low certainty).

• Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants 2022 · Cochrane Headline outcomes only
  RR 0.35
  2 studies · 127 participants
  Low

Early paracetamol vs placebo or no intervention

The review found no eligible studies for this question.

• Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found